Preclinical Data on PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Immune Response

Media Type
Article
Publish or Event Date
Research Institution
CyanVac LLC
Short Title
Preclinical Data on PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Immune Response
Content Coordinator